Small molecules which reverse ductal carcinoma in situ
Canned Analysis
FAIR Metrics
0 evaluations
General Information
AccessionDCA00010417
TitleSmall molecules which reverse ductal carcinoma in situ
DescriptionThe L1000 database was queried in order to identify small molecule perturbations which reverse the ductal carcinoma in situ gene expression signature in the Mammary gland cell type.
Analysis URLhttp://amp.pharm.mssm.edu/L1000CDS2/#/result/58d1cab1e467bea600fb8a0e
Upload DateSeptember 20, 2017
Uploadermaayanlab
Metadata
Analysis Curatorcadimo
CREEDS IDdz:605
Cell TypeMammary gland
DO IDDOID:0060074
Disease Nameductal carcinoma in situ
Organismhuman
L1000CDS2 parameters
Directionreverse
Characteristic Direction parameters
Control SamplesGSM535613, GSM535614, GSM535615, GSM535616, GSM535617
Perturbed SamplesGSM535604, GSM535605, GSM535606, GSM535607, GSM535608, GSM535609, GSM535610, GSM535611, GSM535612
Tools used in the analysis
Dataset Accession
L1000CDS2
Published August 2016
An ultra-fast LINCS L1000 Characteristic Direction signature search engine
7756
Characteristic Direction
Published March 2014
A geometrical multivariate approach to identify differentially expressed genes
26829
Datasets used in the analysis
Keyword
Tool Name
GSE21422
Gene Expression Omnibus
Ductal carcinoma in situ: mammary gland
14
FAIR Evaluation
Sorry, you must be signed in to evaluate this object.